Cooper C - Search Results

1

Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case Report.

Doyle MA, Cooper C. Doyle MA, et al. Among authors: cooper c. Am J Case Rep. 2015 Oct 20;16:745-50. doi: 10.12659/ajcr.895064. Am J Case Rep. 2015. PMID: 26482468 Free PMC article.

2

Therapeutic interventions for HIV infection and chronic viral hepatitis.

Cooper CL. Cooper CL. Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S69-72. doi: 10.1086/429499. Clin Infect Dis. 2005. PMID: 16265617 Review.

3

Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia.

Cooper CL, Al-Bedwawi S, Lee C, Garber G. Cooper CL, et al. Clin Infect Dis. 2006 Jun 15;42(12):1674-8. doi: 10.1086/504386. Epub 2006 May 10. Clin Infect Dis. 2006. PMID: 16705570

4

Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.

Costiniuk CT, Mills E, Cooper CL. Costiniuk CT, et al. Can J Gastroenterol. 2008 Apr;22(4):376-80. doi: 10.1155/2008/725702. Can J Gastroenterol. 2008. PMID: 18414712 Free PMC article. Clinical Trial.

5

Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death.

Costiniuk CT, Camacho F, Cooper CL. Costiniuk CT, et al. Clin Infect Dis. 2008 Jul 15;47(2):198-202. doi: 10.1086/589243. Clin Infect Dis. 2008. PMID: 18532889

6

Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians.

Cooper CL, Bailey RJ, Bain VG, Anderson F, Yoshida EM, Krajden M, Marotta P; Canadian Pegasys Study Group. Cooper CL, et al. Can J Gastroenterol. 2008 Aug;22(8):677-80. doi: 10.1155/2008/320150. Can J Gastroenterol. 2008. PMID: 18701944 Free PMC article.

7

The influence of race and language on chronic hepatitis C virus infection management.

Giordano C, Cooper C. Giordano C, et al. Among authors: cooper c. Eur J Gastroenterol Hepatol. 2009 Feb;21(2):131-6. doi: 10.1097/MEG.0b013e32830b387b. Eur J Gastroenterol Hepatol. 2009. PMID: 19092675 Review.

8

Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes.

Giordano C, Druyts EF, Garber G, Cooper C. Giordano C, et al. Among authors: cooper c. Eur J Gastroenterol Hepatol. 2009 Sep;21(9):963-8. doi: 10.1097/MEG.0b013e328326f598. Eur J Gastroenterol Hepatol. 2009. PMID: 19318966

9

Viral response to specifically targeted antiviral therapy for hepatitis C and the implications for treatment success.

Cooper C. Cooper C. Can J Gastroenterol. 2010 Jun;24(6):385-90. doi: 10.1155/2010/125435. Can J Gastroenterol. 2010. PMID: 20559582 Free PMC article. Review.

10

Reassessing the role for lamivudine in chronic hepatitis B infection: a four-year cohort analysis.

Shaikh T, Cooper C. Shaikh T, et al. Among authors: cooper c. Can J Gastroenterol. 2012 Mar;26(3):148-50. doi: 10.1155/2012/936259. Can J Gastroenterol. 2012. PMID: 22408765 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,172 results

Search Page

Filters